Published: 27 October 2026
Medically reviewed by Dr. Pranay Shah, MS (ObGy), Director & Chief Fertility Consultant, Wellspring IVF & Women’s Hospital, Ahmedabad
Last medically reviewed: 27 October 2026
Transferring two embryos raises the chance of a pregnancy in that one attempt, but it does not raise the chance of eventually taking a baby home. What it reliably raises is the chance of twins. In the trials pooled by Cochrane, multiple pregnancy occurred in 13–15 per cent of double transfers against 2–4 per cent of single transfers, while the cumulative live birth rate after repeated single transfers was statistically no different from one double transfer.
This is the single most misunderstood decision in an IVF cycle, and in India it is often the one couples feel most strongly about. Many arrive at the transfer having already decided they want two embryos put back. The reasoning is usually sound on its own terms: the cycle has been expensive, it has been physically demanding, and putting two embryos in feels like taking two chances instead of one.
The purpose of this article is not to talk anyone out of a preference. It is to set out precisely what changes when a second embryo is added and what does not, what Indian law permits, what the major fertility guidelines actually recommend and why they differ from one another, and which specific factors in an individual couple’s situation genuinely move the answer.
What does “double embryo transfer” actually mean?
Double embryo transfer (DET) means placing two embryos into the uterus in a single transfer procedure. Elective single embryo transfer (eSET) means deliberately placing one, when more than one suitable embryo is available, and keeping the remainder frozen for later use. The word “elective” matters: transferring one embryo because only one exists is not a choice, and is not what the guidelines are discussing.
The comparison that matters clinically is therefore not “one embryo versus two embryos”. It is one embryo now, with the rest frozen for later, versus two embryos now. Framed correctly, the question stops being about how many chances you get and becomes a question about how those chances are spaced out — and about what happens if both of them work at the same time.
Why do so many couples in India ask for two embryos?
Four reasons come up repeatedly in consultation, and none of them is irrational.
- Cost. IVF in India is overwhelmingly self-funded. A couple who has paid for one stimulation cycle wants the maximum return from it.
- Age and time. Couples who have already waited years for treatment feel that a second attempt is a year they do not have.
- Family expectation. Twins are sometimes framed as an efficient outcome — “one pregnancy, family complete” — particularly where there is pressure to produce more than one child.
- A belief that two is simply better. The intuition that two embryos double the odds is very strong and, as the evidence below shows, it is wrong in the way that matters most.
All four deserve a straight answer rather than a lecture, and the rest of this article gives one.
Does transferring two embryos double your chance of a baby?
No. It increases the chance of a live birth from that single transfer, and it does not increase the chance of a live birth from the treatment as a whole.
The most reliable summary of the randomised evidence is the Cochrane systematic review by Kamath and colleagues, updated in 2020, which pooled 17 randomised trials involving 2,505 women. Three findings from it are worth reading carefully, because they are frequently quoted in isolation and each one means something different.
Comparison | What the review found | What it means for you |
|---|---|---|
Live birth from one transfer: single vs double | Single transfer lower (risk ratio 0.67, 95% CI 0.59–0.75). Where double transfer gave a 46% live birth chance, single transfer gave 27–35%. Low-certainty evidence. | If you only ever get one attempt, two embryos give a better result from that attempt. This is the part of the evidence that supports the popular intuition. |
Cumulative live birth: repeated single transfers vs one double transfer | No significant difference (risk ratio 0.95, 95% CI 0.82–1.10). Where double transfer gave 42%, repeated single transfers gave 34–46%. Low-certainty evidence. | Once the frozen embryos are used, the two strategies end in the same place. The advantage above was borrowed from the future, not created. |
Multiple pregnancy | Markedly lower with single transfer (Peto odds ratio 0.16, 95% CI 0.12–0.22). Where double transfer gave a 15% multiple pregnancy rate, single transfer gave 2–4%. Moderate-certainty evidence. | This is the most certain finding of the three, and it is the one that carries the clinical risk. |
Note which finding the reviewers graded most confidently. The benefit of double transfer is low-certainty and disappears over a full course of treatment. The harm is moderate-certainty and does not disappear at all.
What are the risks of a twin pregnancy after IVF?
A twin pregnancy is not a bonus. It is a higher-risk obstetric pregnancy, and it is the mother and the babies who carry that risk, not the treatment cycle.
NICE guideline NG137 on twin and triplet pregnancy states that about 60 in 100 twin pregnancies result in spontaneous birth before 37 weeks. Prematurity is the central problem, and almost everything else follows from it: low birthweight, admission to a neonatal unit, and the medical and financial consequences of neonatal intensive care, which in India is very largely paid out of pocket.
The 2024 ESHRE guideline on the number of embryos to transfer summarises the wider risk profile of multiple pregnancy as including pre-eclampsia, gestational diabetes, haemorrhage, caesarean delivery, stillbirth, prematurity and neonatal death. The ESHRE group’s overall conclusion is unusually direct: no clinical or embryological factor, taken on its own, justifies double transfer instead of elective single transfer.
It is worth being explicit about what this does and does not say. It does not say that twins are a catastrophe, and it does not say that families with twins have done something wrong. Most twin pregnancies end well. It says that a course of treatment which produces one healthy baby at a time is safer than one which produces two at once, and that when the same number of babies is achievable either way, the safer route is the better medicine.
What does Indian law allow — and why do guidelines recommend less?
India has a statutory ceiling, and it is higher than what any current fertility guideline recommends. Section 24(b) of the Assisted Reproductive Technology (Regulation) Act, 2021 provides that, among the duties of ART clinics, “not more than three oocytes or embryos may be placed in the uterus of a woman during the treatment cycle in such manner as may be specified by regulations”.
Three is therefore the legal maximum in India. It is not a clinical recommendation, and no couple should read it as one. A legal ceiling defines what a clinic may not exceed; it does not describe good practice, in the same way that a speed limit is not a suggested speed.
Source | Position on number of embryos |
|---|---|
ART (Regulation) Act, 2021, section 24(b) — India | Maximum of three oocytes or embryos may be placed in the uterus in a treatment cycle. A legal ceiling. |
NICE guideline NG257 (2026) — United Kingdom | Recommendation 1.49.8: “Do not transfer more than 2 embryos during any 1 cycle of IVF treatment.” Recommendation 1.49.9: “Where a top-quality blastocyst is available, use single embryo transfer.” |
ESHRE guideline (2024) — Europe | Elective single embryo transfer recommended for women both under and over 38; transfer of more than two embryos is not recommended; no single factor justifies double transfer. |
ASRM committee opinion (2021) — United States | Single embryo transfer for any euploid embryo regardless of age; women under 35 strongly encouraged to have single transfer; higher numbers permitted only with documented justification in poorer-prognosis groups. |
The practical consequence for an Indian patient is that the gap between “legal” and “recommended” has to be closed by the treating clinician, because the law will not close it. A clinic that offers three embryos because the Act permits three is operating lawfully and, on current evidence, is not practising to guideline standard.
What do the guidelines recommend at different ages?
The three major guidelines agree on the direction of travel and differ on the details, which is itself informative. Where authorities disagree, the honest position is to show the disagreement rather than quote whichever one supports the answer you already wanted.
Maternal age | NICE NG257 (2026) | ESHRE (2024) | ASRM (2021) |
|---|---|---|---|
Under 37 | Single embryo transfer in the first cycle; single in the second cycle if a top-quality embryo is available; no more than two in the third cycle | Elective single embryo transfer | One euploid or favourable blastocyst; single transfer strongly encouraged under 35 |
37–39 | Single transfer in the first and second cycles where top-quality embryos are available; double transfer considered otherwise; no more than two in the third cycle | Elective single embryo transfer | One euploid or favourable blastocyst at 35–37; up to two favourable blastocysts at 38–40 |
40 and above | Double embryo transfer may be considered at 40–41 | Elective single embryo transfer; the recommendation is not relaxed by age | One euploid blastocyst at any age; up to three favourable blastocysts at 41–42 |
Any age, euploid embryo after genetic testing | Single transfer where a top-quality blastocyst is available | Single transfer regardless of blastocyst quality | Single transfer, regardless of age |
Two things stand out. First, every one of them recommends a single embryo when a genetically tested, chromosomally normal embryo is available — there is no age at which two euploid embryos are advised. Second, the only significant relaxation for age appears in the NICE and ASRM documents and applies to women in their forties with embryos that have not been shown to be favourable. ESHRE declines to relax it at all, on the reasoning that the cumulative result does not improve while the multiple pregnancy risk does.
When is single embryo transfer clearly the right choice?
Single transfer is the straightforward recommendation where any of the following applies:
- A chromosomally normal (euploid) embryo is available after genetic testing — all three guidelines agree here without qualification.
- A good-quality blastocyst is available. ESHRE’s position is that single transfer applies regardless of the blastocyst’s grade; NICE ties it to a top-quality blastocyst.
- The woman is under 37 and in her first treatment cycle.
- There is any maternal condition that makes a twin pregnancy more dangerous — including a uterine scar from previous caesarean section, uterine anomaly, significant medical illness, short stature with a small pelvis, previous preterm birth, or a cervix that has previously required intervention.
- The pregnancy is being carried by a gestational surrogate, or the embryos were created from donor oocytes. ESHRE recommends single transfer only in these situations, without exception.
Is there ever a genuine case for transferring two?
Yes, and the case should be made honestly rather than dismissed. NICE explicitly permits consideration of double transfer at ages 40–41, and in earlier cycles at 37–39 where no top-quality embryo is available. ASRM permits more than one embryo in defined poorer-prognosis situations provided the justification is documented. Both are describing the same situation: a woman whose realistic number of future attempts is small and whose embryos are not of a quality that predicts a good result on their own.
What is not a good reason is any of the following: a wish for twins; a general sense that more must be better; a previous failed transfer treated as evidence that one embryo “does not work”; or the assumption that a second embryo compensates for a poor-quality first one. The evidence does not support any of these, and the ESHRE group examined embryo criteria specifically and found that they do not justify the change.
Where double transfer is being considered, NICE recommendation 1.49.10 requires that the risks of multiple pregnancy are discussed. That discussion is part of the standard of care, not an optional extra, and any couple who is offered two embryos without it has not been fully counselled.
Does embryo quality change the answer?
Less than most people expect. Growing embryos to day five and selecting a blastocyst is the single most useful way of identifying which embryo has the best chance, and blastocyst culture is precisely what makes a confident single transfer possible. But the ESHRE guideline group examined whether a poor-looking blastocyst justifies putting two back and concluded that it does not: single transfer should be applied regardless of the quality of a vitrified blastocyst, and the decision to perform double transfer should not be based on embryo criteria at either the cleavage or the blastocyst stage.
The reasoning is worth understanding. A weaker embryo has a lower chance of implanting — but if two weaker embryos are transferred and both implant, the resulting twin pregnancy is no safer for having started from lower-grade embryos. The risk is not scaled down to match the odds.
The cost argument, examined honestly
The economic case for double transfer is the one couples raise most often, and it is the one that changes most once the whole treatment course is considered rather than a single procedure.
A stimulated IVF cycle that produces several good embryos has already generated more than one attempt. When one embryo is transferred and the rest go into embryo freezing, a second attempt does not require another stimulation, another egg collection or another anaesthetic — the surplus embryos are thawed and used in a later embryo transfer, which is a substantially smaller procedure than a full cycle. Couples planning their finances should look at what an IVF cycle costs as a course of treatment rather than as one transfer, because that is how the cumulative evidence above is actually generated.
Against this must be set the cost that a twin pregnancy can impose: a higher likelihood of preterm delivery, of caesarean section, and of neonatal intensive care. A single twin admission to a neonatal unit can exceed the cost of the additional frozen transfer that was being avoided. This is a real financial argument in the Indian context and it points in the same direction as the clinical one.
A framework for your own decision
Factor | Does it change the recommendation? | Why |
|---|---|---|
A euploid embryo is available after genetic testing | Yes — single transfer, at any age | All three guidelines agree; a second embryo adds multiple pregnancy risk without a corresponding cumulative gain |
Good-quality blastocyst available | Yes — single transfer | NICE 1.49.9; ESHRE recommends single transfer regardless of blastocyst grade |
Age 40 or above with no top-quality embryo | Possibly — double transfer may be considered | Permitted by NICE at 40–41 and by ASRM with documentation; ESHRE still recommends single |
Previous caesarean, uterine anomaly, or medical illness | Yes — single transfer | Twin pregnancy substantially raises obstetric risk on an already compromised uterus or in maternal illness |
Donor oocytes or a gestational surrogate | Yes — single transfer only | ESHRE recommends single transfer without exception in these groups |
Surplus embryos available for freezing | Yes — single transfer | The cumulative live birth rate is preserved; nothing is lost, only deferred |
Cost pressure or a wish to finish treatment quickly | No | Understandable, but the cumulative result is unchanged and neonatal costs can exceed the saving |
A previous failed single transfer | No, by itself | The correct response is to investigate why it failed, not to add an embryo |
A wish for twins | No | Deliberately aiming for a higher-risk pregnancy is not an accepted clinical goal |
When should you discuss this with a fertility specialist?
Before the stimulation starts, not on the morning of the transfer. The number of embryos to transfer is decided far more calmly when it is discussed alongside the stimulation protocol and the freezing plan, because at that point it is a strategy for the whole treatment course. On transfer day, with a fresh embryo report in hand and a procedure booked in an hour, it becomes an emotional decision made under time pressure.
The questions worth asking are: how many embryos are expected to be suitable for freezing; what the plan is if only one embryo develops; whether there is anything in the uterus, the obstetric history or the medical history that would make a twin pregnancy more dangerous; and what the clinic’s own policy on transfer numbers is and why.
Frequently asked questions
Is transferring two embryos better than one?
Not over a full course of treatment. Two embryos improve the chance of a live birth from that one transfer, but the cumulative live birth rate after repeated single transfers is statistically no different from one double transfer, while the multiple pregnancy rate is several times higher. The recognised international guidelines therefore recommend single transfer as the default.
How many embryos can legally be transferred in India?
Section 24(b) of the ART (Regulation) Act, 2021 permits a maximum of three oocytes or embryos to be placed in the uterus during a treatment cycle. This is a legal ceiling rather than a clinical recommendation; NICE advises no more than two in any cycle and ESHRE advises against transferring more than two.
Will single embryo transfer mean my treatment takes longer?
It can mean more than one transfer, but not more than one stimulation cycle, because the additional embryos are already frozen. In practice a second frozen transfer is usually a matter of weeks, not another full treatment episode.
If both my embryos are poor quality, should I transfer both?
The ESHRE guideline group examined this question specifically and concluded that the decision to transfer two embryos should not be based on embryo criteria. A twin pregnancy resulting from two lower-grade embryos carries the same obstetric risk as any other twin pregnancy.
Does a single embryo transfer reduce my chance if I am over 40?
This is the one area where the guidelines genuinely differ. NICE permits double transfer to be considered at 40–41 and ASRM permits more than one embryo in poorer-prognosis situations with documented justification, whereas ESHRE recommends elective single transfer irrespective of age. The decision should be individualised on the number of embryos available, their quality, and any obstetric or medical factors that would make a twin pregnancy more dangerous.
What if only one embryo develops?
Then there is no decision to make — a single embryo is transferred. The single-versus-double discussion only arises where more than one suitable embryo exists.
The takeaway
Adding a second embryo does not add a second baby to your eventual chances; it moves a chance forward in time and adds the risk that both implant at once. For most couples, most of the time, the safest route to a healthy baby is one embryo at a time with the rest frozen — and the strongest arguments for that are the ones that come from obstetrics rather than from embryology.
Where the picture is less clear — a woman in her forties, a small number of embryos, a history of failed transfers — the answer should be individualised, discussed before the cycle begins, and documented. What it should never be is a decision taken quickly on transfer day on the assumption that more must be better.
Couples planning an IVF cycle, or weighing up how many embryos to transfer, can discuss their individual situation with a fertility specialist at Wellspring IVF & Women’s Hospital, Ahmedabad. Call or WhatsApp +91 9099946050. OPD hours are Monday to Saturday, 10:00 AM to 4:00 PM.
References
- Kamath MS, Mascarenhas M, Kirubakaran R, Bhattacharya S. Number of embryos for transfer in women undergoing assisted reproductive technology (ART). Cochrane Database of Systematic Reviews, 2020. https://www.cochrane.org/evidence/CD003416
- ESHRE Guideline Group on the Number of Embryos to Transfer. ESHRE guideline: number of embryos to transfer during IVF/ICSI. Human Reproduction, 2024;39(4):647–657. https://academic.oup.com/humrep/article/39/4/647/7607249
- ESHRE. Number of embryos to transfer during IVF/ICSI — guideline main document, 2023. https://www.eshre.eu/-/media/sitecore-files/Guidelines/Embryo-transfer/
- National Institute for Health and Care Excellence. Fertility problems: assessment and treatment. NICE guideline NG257, published 31 March 2026 (updates and replaces CG156). https://www.nice.org.uk/guidance/ng257/
- National Institute for Health and Care Excellence. Twin and triplet pregnancy. NICE guideline NG137, published 4 September 2019, updated 9 April 2024. https://www.nice.org.uk/guidance/ng137/
- Practice Committee of the American Society for Reproductive Medicine. Guidance on the limits to the number of embryos to transfer: a committee opinion. Fertility and Sterility, 2021;116:651–654. https://www.asrm.org/practice-guidance/
- Government of India. The Assisted Reproductive Technology (Regulation) Act, 2021 (Act No. 42 of 2021), section 24(b). https://www.indiacode.nic.in/bitstream/123456789/17031/1/aA2021-42.pdf
